FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097498243> ?p ?o ?g. }

• W2097498243 endingPage "303" @default.
• W2097498243 startingPage "303" @default.
• W2097498243 abstract "Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycemic control to photocoagulation and more recently the use of vascular endothelial growth factor (VEGF) antagonists. The index review discusses aflibercept (EYLEA(®)-Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, and Bayer Healthcare Pharmaceuticals, Berlin, Germany) in the context of other VEGF antagonists currently available for the treatment of DME. A systematic search of literature was conducted on PubMed, Scopus, and Google Scholar with no limitation on language or year of publication. Pre-clinical studies of aflibercept have shown a higher affinity of this molecule for vascular endothelial growth factor A (VEGF-A) along with a longer duration of action as compared to other VEGF antagonists. Recent clinical trials have shown visual outcome results for aflibercept to be similarly favorable as compared to other available agents with the added benefit of fewer required injections and less frequent monitoring. Aflibercept presents a potential exciting new addition to the armamentarium of current VEGF antagonists available for the treatment of DME and other retinal vascular diseases. However, further studies are indicated to confirm the role, safety, and efficacy of aflibercept for DME." @default.
• W2097498243 created "2016-06-24" @default.
• W2097498243 creator A5004807592 @default.
• W2097498243 creator A5010289666 @default.
• W2097498243 creator A5033277817 @default.
• W2097498243 creator A5051993498 @default.
• W2097498243 creator A5056393739 @default.
• W2097498243 creator A5080631815 @default.
• W2097498243 creator A5083194466 @default.
• W2097498243 creator A5091022089 @default.
• W2097498243 date "2013-01-01" @default.
• W2097498243 modified "2023-09-26" @default.
• W2097498243 title "Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema" @default.
• W2097498243 cites W1039234313 @default.
• W2097498243 cites W127872553 @default.
• W2097498243 cites W1496977463 @default.
• W2097498243 cites W1526282761 @default.
• W2097498243 cites W1679089852 @default.
• W2097498243 cites W1974872555 @default.
• W2097498243 cites W1979149433 @default.
• W2097498243 cites W1980725734 @default.
• W2097498243 cites W1983943345 @default.
• W2097498243 cites W1984158303 @default.
• W2097498243 cites W2004643661 @default.
• W2097498243 cites W2010599103 @default.
• W2097498243 cites W2022878833 @default.
• W2097498243 cites W2036712095 @default.
• W2097498243 cites W2057983131 @default.
• W2097498243 cites W2079713841 @default.
• W2097498243 cites W2091245553 @default.
• W2097498243 cites W2103965396 @default.
• W2097498243 cites W2121919167 @default.
• W2097498243 cites W2123123877 @default.
• W2097498243 cites W2128535483 @default.
• W2097498243 cites W2142693543 @default.
• W2097498243 cites W2143874967 @default.
• W2097498243 cites W2144003837 @default.
• W2097498243 cites W2156799887 @default.
• W2097498243 cites W2161588304 @default.
• W2097498243 cites W2165344522 @default.
• W2097498243 cites W2324588265 @default.
• W2097498243 cites W2616361514 @default.
• W2097498243 cites W2081847856 @default.
• W2097498243 cites W2100954833 @default.
• W2097498243 doi "https://doi.org/10.4239/wjd.v4.i6.303" @default.
• W2097498243 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3874490" @default.
• W2097498243 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24379921" @default.
• W2097498243 hasPublicationYear "2013" @default.
• W2097498243 type Work @default.
• W2097498243 sameAs 2097498243 @default.
• W2097498243 citedByCount "26" @default.
• W2097498243 countsByYear W20974982432013 @default.
• W2097498243 countsByYear W20974982432014 @default.
• W2097498243 countsByYear W20974982432015 @default.
• W2097498243 countsByYear W20974982432016 @default.
• W2097498243 countsByYear W20974982432017 @default.
• W2097498243 countsByYear W20974982432018 @default.
• W2097498243 countsByYear W20974982432019 @default.
• W2097498243 countsByYear W20974982432020 @default.
• W2097498243 countsByYear W20974982432021 @default.
• W2097498243 countsByYear W20974982432022 @default.
• W2097498243 countsByYear W20974982432023 @default.
• W2097498243 crossrefType "journal-article" @default.
• W2097498243 hasAuthorship W2097498243A5004807592 @default.
• W2097498243 hasAuthorship W2097498243A5010289666 @default.
• W2097498243 hasAuthorship W2097498243A5033277817 @default.
• W2097498243 hasAuthorship W2097498243A5051993498 @default.
• W2097498243 hasAuthorship W2097498243A5056393739 @default.
• W2097498243 hasAuthorship W2097498243A5080631815 @default.
• W2097498243 hasAuthorship W2097498243A5083194466 @default.
• W2097498243 hasAuthorship W2097498243A5091022089 @default.
• W2097498243 hasBestOaLocation W20974982431 @default.
• W2097498243 hasConcept C118487528 @default.
• W2097498243 hasConcept C126322002 @default.
• W2097498243 hasConcept C134018914 @default.
• W2097498243 hasConcept C141071460 @default.
• W2097498243 hasConcept C151730666 @default.
• W2097498243 hasConcept C167734588 @default.
• W2097498243 hasConcept C2776694085 @default.
• W2097498243 hasConcept C2777025900 @default.
• W2097498243 hasConcept C2777512022 @default.
• W2097498243 hasConcept C2777802072 @default.
• W2097498243 hasConcept C2778257484 @default.
• W2097498243 hasConcept C2778749236 @default.
• W2097498243 hasConcept C2779343474 @default.
• W2097498243 hasConcept C2779829184 @default.
• W2097498243 hasConcept C2780347916 @default.
• W2097498243 hasConcept C2780473172 @default.
• W2097498243 hasConcept C2781100027 @default.
• W2097498243 hasConcept C2985127711 @default.
• W2097498243 hasConcept C555293320 @default.
• W2097498243 hasConcept C71924100 @default.
• W2097498243 hasConcept C86803240 @default.
• W2097498243 hasConceptScore W2097498243C118487528 @default.
• W2097498243 hasConceptScore W2097498243C126322002 @default.
• W2097498243 hasConceptScore W2097498243C134018914 @default.
• W2097498243 hasConceptScore W2097498243C141071460 @default.
• W2097498243 hasConceptScore W2097498243C151730666 @default.

• next